Learn how Johnson & Johnson Innovative Medicine is transforming the future of healthcare and leading where medicine is going.
Learn how Johnson & Johnson Innovative Medicine is transforming the future of healthcare and leading where medicine is going.
President, Oncology, Johnson & Johnson Innovative Medicine. “We intend to lead where hematology is going so patients can ultimately live longer, better lives.” Accelerating innovative therapies across all lines of treatment in multiple...
Learn how Johnson & Johnson Innovative Medicine is transforming the future of healthcare and leading where medicine is going.
Learn how Johnson & Johnson Innovative Medicine is transforming the future of healthcare and leading where medicine is going.
Acquisition strengthens Johnson & Johnson’s commitment to innovation in prostate cancer and deepens pipeline of next-generation antibody drug conjugates and targeted oncologic therapeutics
Oncology With unwavering determination, we’re working toward a bold ambition — to eliminate cancer. Know more Immunology We’re helping patients with immune-mediated disease reclaim their lives by delivering transformational and accessible therapies. Know more Neuroscience Our mission is to ...
Grant funding from a total pool of up to $250,000, access to the global Johnson & Johnson Innovation – JLABS network, and mentorship. Days remaining Closed OncologyInnovation Challenges Pitching ADC Advancements QuickFire Challenge Dubbed ‘the next pillar of cancer therapeutics’, Antibody Drug Co...
Learn how Johnson & Johnson Innovative Medicine is transforming the future of healthcare and leading where medicine is going.
“The Ambrx team has developed a promising pipeline and ADC platform that will be a strong complement and strategic fit to our oncology innovation strategy,” said Biljana Naumovic, Worldwide Vice President, Oncology, Johnson & Johnson Innovative Medicine. “ADCs are transforming the solid tumor tr...